Vasculitis-like Palpable Purpuric Rash Induced by Decapeptyl in a Pediatric Patient Diagnosed Central Precocious Puberty

Central precocious puberty (CPP) is defined as the appearance of secondary sexual signs in girls younger than eight years of age or the onset of menarche before the age of 10 years. Gonadotropin-releasing hormone analogs (GnRHa) are the most effective therapy in CPP. Drug-induced hypersensitivity va...

Full description

Bibliographic Details
Main Authors: Nilüfer Galip, Nermin Ankay, Rüveyde Bundak
Format: Article
Language:English
Published: Galenos Yayincilik 2023-09-01
Series:JCRPE
Subjects:
Online Access:https://jcrpe.org/jvi.aspx?pdir=jcrpe&plng=eng&un=JCRPE-32032&look4=
_version_ 1797737592520704000
author Nilüfer Galip
Nermin Ankay
Rüveyde Bundak
author_facet Nilüfer Galip
Nermin Ankay
Rüveyde Bundak
author_sort Nilüfer Galip
collection DOAJ
description Central precocious puberty (CPP) is defined as the appearance of secondary sexual signs in girls younger than eight years of age or the onset of menarche before the age of 10 years. Gonadotropin-releasing hormone analogs (GnRHa) are the most effective therapy in CPP. Drug-induced hypersensitivity vasculitis is an inflammation of blood vessels, which may be due to the use of a number of pharmacologic agents. This case report describes drug-induced vasculitis in a girl being treated with Decapeptyl. A 7.25 year-old girl was admitted to Pediatric Endocrinology outpatients with premature breast development. She was diagnosed with CPP on the basis of physical examination and laboratory findings and tripoteline acetate (Decapeptyl®) treatment was initiated. She experienced multiple widespread skin rashes and mild abdominal pain with high temperature eight hours after the second dose of Decapeptyl. She was admitted to hospital with the diagnosis of drug-induced vasculitis and a single dose of intravenous methyl-prednisolone (1 mg/kg) and oral cetirizine was given. Her blood and urine analysis revealed no other organ involvement, other than skin. On the third day, the purpuric lesions began to resolve and had completely disappeared by the sixth day. Her treatment for CPP was switched to Depot Leuprolide acetate and she continued her treatment for two years uneventfully. To the best of our knowledge, this is the first report of a child with CPP experiencing drug-induced vasculitis due to tripotelin injection. Effective treatment may be continued by switching to an alternative gonadotropin releasing hormone analog.
first_indexed 2024-03-12T13:31:37Z
format Article
id doaj.art-97f4d75d103c49c3b084eae2ae027099
institution Directory Open Access Journal
issn 1308-5727
1308-5735
language English
last_indexed 2024-03-12T13:31:37Z
publishDate 2023-09-01
publisher Galenos Yayincilik
record_format Article
series JCRPE
spelling doaj.art-97f4d75d103c49c3b084eae2ae0270992023-08-24T11:28:46ZengGalenos YayincilikJCRPE1308-57271308-57352023-09-0115330731110.4274/jcrpe.galenos.2021.2021.0205JCRPE-32032Vasculitis-like Palpable Purpuric Rash Induced by Decapeptyl in a Pediatric Patient Diagnosed Central Precocious PubertyNilüfer Galip0https://orcid.org/0000-0002-6982-2083Nermin Ankay1https://orcid.org/0000-0003-4642-221XRüveyde Bundak2https://orcid.org/0000-0001-5097-6448University of Kyrenia, Faculty of Medicine, Department of Pediatrics, Division of Pediatric Allergy and Clinical Immunology, Kyrenia, North CyprusDr. Burhan Nalbantoğlu State Hospital, Clinic of Pediatrics, Nicosia, North CyprusUniversity of Kyrenia, Faculty of Medicine, Department of Pediatrics, Division of Pediatric Endocrinology, Kyrenia, North CyprusCentral precocious puberty (CPP) is defined as the appearance of secondary sexual signs in girls younger than eight years of age or the onset of menarche before the age of 10 years. Gonadotropin-releasing hormone analogs (GnRHa) are the most effective therapy in CPP. Drug-induced hypersensitivity vasculitis is an inflammation of blood vessels, which may be due to the use of a number of pharmacologic agents. This case report describes drug-induced vasculitis in a girl being treated with Decapeptyl. A 7.25 year-old girl was admitted to Pediatric Endocrinology outpatients with premature breast development. She was diagnosed with CPP on the basis of physical examination and laboratory findings and tripoteline acetate (Decapeptyl®) treatment was initiated. She experienced multiple widespread skin rashes and mild abdominal pain with high temperature eight hours after the second dose of Decapeptyl. She was admitted to hospital with the diagnosis of drug-induced vasculitis and a single dose of intravenous methyl-prednisolone (1 mg/kg) and oral cetirizine was given. Her blood and urine analysis revealed no other organ involvement, other than skin. On the third day, the purpuric lesions began to resolve and had completely disappeared by the sixth day. Her treatment for CPP was switched to Depot Leuprolide acetate and she continued her treatment for two years uneventfully. To the best of our knowledge, this is the first report of a child with CPP experiencing drug-induced vasculitis due to tripotelin injection. Effective treatment may be continued by switching to an alternative gonadotropin releasing hormone analog.https://jcrpe.org/jvi.aspx?pdir=jcrpe&plng=eng&un=JCRPE-32032&look4=drug-inducedcentral precocious pubertyvasculitisvasculitis-like rash
spellingShingle Nilüfer Galip
Nermin Ankay
Rüveyde Bundak
Vasculitis-like Palpable Purpuric Rash Induced by Decapeptyl in a Pediatric Patient Diagnosed Central Precocious Puberty
JCRPE
drug-induced
central precocious puberty
vasculitis
vasculitis-like rash
title Vasculitis-like Palpable Purpuric Rash Induced by Decapeptyl in a Pediatric Patient Diagnosed Central Precocious Puberty
title_full Vasculitis-like Palpable Purpuric Rash Induced by Decapeptyl in a Pediatric Patient Diagnosed Central Precocious Puberty
title_fullStr Vasculitis-like Palpable Purpuric Rash Induced by Decapeptyl in a Pediatric Patient Diagnosed Central Precocious Puberty
title_full_unstemmed Vasculitis-like Palpable Purpuric Rash Induced by Decapeptyl in a Pediatric Patient Diagnosed Central Precocious Puberty
title_short Vasculitis-like Palpable Purpuric Rash Induced by Decapeptyl in a Pediatric Patient Diagnosed Central Precocious Puberty
title_sort vasculitis like palpable purpuric rash induced by decapeptyl in a pediatric patient diagnosed central precocious puberty
topic drug-induced
central precocious puberty
vasculitis
vasculitis-like rash
url https://jcrpe.org/jvi.aspx?pdir=jcrpe&plng=eng&un=JCRPE-32032&look4=
work_keys_str_mv AT nilufergalip vasculitislikepalpablepurpuricrashinducedbydecapeptylinapediatricpatientdiagnosedcentralprecociouspuberty
AT nerminankay vasculitislikepalpablepurpuricrashinducedbydecapeptylinapediatricpatientdiagnosedcentralprecociouspuberty
AT ruveydebundak vasculitislikepalpablepurpuricrashinducedbydecapeptylinapediatricpatientdiagnosedcentralprecociouspuberty